摘要
Purpose The aim of this study was to explore the role of galectin-3 in human epidermal growth factor receptor 2 (HER2)-positive breast cancer cells and the potential mechanism. Methods Kaplan-Meier (KM)-plot and The Cancer Genome Atlas (TCGA) databases were used to study the role of galectin-3 in the prognosis of HER2-positive breast cancer. The effects of galectin-3 on cell proliferation, migration, invasion, and colony formation ability in HER2-positive breast cancer cells were examined. The relationship between galectin-3 and important components in the HER2 pathways, including HER2, epidermal growth factor receptor (EGFR), protein kinase B (AKT), and phosphatase and tensin homolog (PTEN), was further studied. Lentivirus and CRISPR/Cas9 were used to construct stable cell lines. Cell counting kit-8 (CCK-8) and apoptosis assays were used to study the relationship between galectin-3 and trastuzumab. The effect of galectin-3 on cell stemness was studied by mammosphere formation assay. The effects of galectin-3 on stemness biomarkers and the Notch1 pathway were examined. Tumorigenic models were used to evaluate the effects of galectin-3 on tumorigenesis and the therapeutic effect of trastuzumab in vivo. Results HER2-positive breast cancer patients with a high expression level of LGALS3 (the gene encoding galectin-3) messenger RNA (mRNA) showed a poor prognosis. Galectin-3 promoted cancer malignancy through phosphoinositide 3-kinase (PI3K)/AKT signaling pathway activation and upregulated stemness by activating the Notch1 signaling pathway in HER2-positive breast cancer cells. These two factors contributed to the enhancement of trastuzumab resistance in cells. Knockout of LGALS3 had a synergistic therapeutic effect with trastuzumab both in vitro and in vivo. Conclusions Galectin-3 may represent a prognostic predictor and therapeutic target for HER2-positive breast cancer.
学科与关键词
- Inhibition of PFKFB3 in HER2-positive gastric cancer improves sensitivity to trastuzumab by inducing tumour vessel normalisationYao, Xingxing; He, Zhanke; Qin, Caolitao; Zhang, Penghao; Sui, Chuyang; Deng, Xiangqian; Fang, Yuxin; Li, Guoxin*; Shi, Jiaolong*British Journal of Cancer, 2022, 127(5): 811-823.被引 4
- ?-catenin promotes resistance to trastuzumab in breast cancer cells through enhancing interaction between HER2 and SRCHao, Xiaoyan; Zheng, Jialu; Yu, Xiaoqin; Li, Zhixin; Ren, Guanghui*ACTA BIOCHIMICA POLONICA, 2023, 70(2): 261-269.被引 1
- miR-301a-3p induced by endoplasmic reticulum stress mediates the occurrence and transmission of trastuzumab resistance in HER2-positive gastric cancerGuo, Jing; Zhong, Xuxian; Tan, Qinglin; Yang, Shengnan; Liao, Jiaqi; Zhuge, Jinke; Hong, Ziyang; Deng, Qiong; Zuo, Qiang*Cell Death & Disease, 2021, 12(7): 696.被引 14
